Robert Alexander Allakos Inc. (ALLK) insider trading activity

Robert Alexander is Chief Executive Officer of Allakos Inc.. Currently has a direct ownership of 836,251 shares of ALLK, which is worth approximately $769,350. The most recent transaction as insider was on Jun 06, 2024, when has been sold 37,525 shares (Common Stock) at a price of $1.14 per share, resulting in proceeds of $42,778. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 836K

4.29% 3M change

12.7% 12M change

Total Value Held $769,350

Robert Alexander Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 06 2024	SELL Payment of exercise price or tax liability	$42,778 $1.14 p/Share	37,525 Reduced 4.29%	836,251 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$104,946 $1.48 p/Share	70,910 Reduced 7.51%	873,776 Common Stock
Dec 04 2023	SELL Payment of exercise price or tax liability	$61,882 $2.5 p/Share	24,753 Reduced 2.56%	941,686 Common Stock
Sep 05 2023	SELL Payment of exercise price or tax liability	$84,568 $3.01 p/Share	28,096 Reduced 2.83%	966,439 Common Stock
Jun 02 2023	SELL Payment of exercise price or tax liability	$135,508 $5.13 p/Share	26,415 Reduced 2.68%	957,862 Common Stock
Mar 08 2023	SELL Payment of exercise price or tax liability	$413,549 $6.24 p/Share	66,274 Reduced 6.31%	984,277 Common Stock
Mar 07 2023	SELL Payment of exercise price or tax liability	$58,515 $6.4 p/Share	9,143 Reduced 0.86%	1,050,551 Common Stock

Jan 06 2023	BUY Grant, award, or other acquisition	-	301,575 Added 22.2%	1,056,694 Common Stock
Dec 02 2022	SELL Payment of exercise price or tax liability	$122,882 $8.11 p/Share	15,152 Reduced 1.97%	755,119 Common Stock
Sep 02 2022	SELL Payment of exercise price or tax liability	$37,755 $4.54 p/Share	8,316 Reduced 1.07%	770,271 Common Stock
Jun 02 2022	SELL Payment of exercise price or tax liability	$22,231 $2.75 p/Share	8,084 Reduced 1.03%	778,587 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$44,197 $5.38 p/Share	8,215 Reduced 1.03%	786,671 Common Stock
Feb 25 2022	BUY Grant, award, or other acquisition	-	529,323 Added 39.97%	794,886 Common Stock
Dec 02 2021	SELL Payment of exercise price or tax liability	$1,592,764 $78.69 p/Share	20,241 Reduced 7.09%	265,250 Common Stock
Dec 01 2021	BUY Grant, award, or other acquisition	-	51,681 Added 15.33%	285,491 Common Stock
Sep 02 2021	SELL Payment of exercise price or tax liability	$365,265 $91.66 p/Share	3,985 Reduced 1.68%	233,810 Common Stock
Jun 04 2021	SELL Open market or private sale	$1,623,468 $89.63 p/Share	18,113 Reduced 7.08%	237,795 Common Stock
Jun 04 2021	BUY Exercise of conversion of derivative security	$10,016 $0.69 p/Share	14,516 Added 5.44%	252,311 Common Stock
Jun 03 2021	SELL Open market or private sale	$1,337,596 $92.14 p/Share	14,517 Reduced 5.59%	245,395 Common Stock
Jun 03 2021	SELL Payment of exercise price or tax liability	$369,077 $92.2 p/Share	4,003 Reduced 1.63%	241,392 Common Stock
Jun 03 2021	BUY Exercise of conversion of derivative security	$10,017 $0.69 p/Share	14,517 Added 5.29%	259,912 Common Stock
Jun 02 2021	SELL Open market or private sale	$1,372,582 $94.55 p/Share	14,517 Reduced 5.59%	245,395 Common Stock
Jun 02 2021	BUY Exercise of conversion of derivative security	$10,017 $0.69 p/Share	14,517 Added 5.29%	259,912 Common Stock
May 19 2021	SELL Open market or private sale	$1,436,213 $98.94 p/Share	14,516 Reduced 5.58%	245,395 Common Stock
May 19 2021	BUY Exercise of conversion of derivative security	$10,016 $0.69 p/Share	14,516 Added 5.29%	259,911 Common Stock

Also insider at

ALNA

Allena Pharmaceuticals, Inc. Healthcare

Director